New from February 2020: The world of cancer treatment is changing rapidly, therefore we’ve added new content on immunotherapies, such as checkpoint inhibitors, CAR T cells, PARP inhibitors and CDK inhibitors.
Although the course is open to all, it has been designed primarily for clinical research nurses working with patients on clinical cancer trials, along with clinical cancer research staff and specialist cancer nurses. See more information below.
Thanks to ground-breaking research over the past 20 years, new, more targeted treatments and immunotherapies have been developed that are changing the way we treat cancer, and providing new hope for patients. Join us and discover the science behind these treatments and learn through quizzes, interviews, articles and patient case studies. Each week you’ll have the opportunity to engage in discussion with other learners on key issues. You’ll learn from experts in the field and gain a deeper understanding of how targeted cancer treatments and immunotherapies work to support your patients.
You may notice little or no facilitation from the course’s lead educators and mentors at this time. However, we’d encourage you to follow and join in discussion with other learners, share your experience and knowledge, and hear different perspectives to enhance your learning experience. We hope that you will enjoy interacting with and learning from each other in this way. Don’t forget to comment, reply to other learners and ‘like’ comments.
This course has been designed primarily for clinical cancer research nurses, along with other members of the clinical cancer research team. It can go towards your Continuing Professional Development (CPD) and/or revalidation with the Nursing and Midwifery Council.
The course is also relevant for and may be of interest to specialist cancer nurses and other health professionals including pharmacists and medical/science graduates studying this topic.
A basic understanding of how cells work is needed to get the most out of this course. Some experience working in cancer is also recommended.
Register to leave a review